OBiSOBiS
  • About Us
  • Products & Services
  • Exploratory Projects
  • News
  • Contact Us

  • Rani Therapeutics falls short of IPO projections with $73M for robotic biologic pill
  • Insilico Medicine’s AI engines continue to churn out new drug candidates, now in kidney fibrosis
  • Synthetic biology outfit Zymergen sees fledgling stock tumble amid CEO departure, product delays
  • Philips faces 2nd Class I recall in a month, this time for high-flow therapy ventilators
  • Lundbeck bulks up neuro portfolio with $10M Rgenta pact after ditching Alzheimer's drug

© 2021 OBiS Inc, All Rights Reserved

  • About Us
  • Products & Services
  • Exploratory Projects
  • News
  • Contact Us